You are here: Home » Switch to Serdolect » Efficacy » Efficacy vs. comparators

Superior to risperidone on negative symptoms

Serdolect compares favourably to other atypical antipsychotics in terms of efficacy.

Serdolect demonstrated clinically relevant efficacy advantages over risperidone.

Published: 02/02/2007 Last updated: 18/05/2010

Switch to Serdolect

Literature Search

PubMed
Google Scholar

Study duration 12 weeks

Serdolect significantly superior to risperidone on negative symptoms

In addition, exploratory repeated measures analyses showed Serdolect to be significantly superior to risperidone on positive (p<0.01) and negative (p<0.01) symptoms using OC data set (not shown in figure) (Ref. 1).

References:

1. Azorin et al. Int Clin Psycho-pharmacol 2006; 21: 49-56